CA Final · Integrated Business Solutions (Multidisciplinary Case Study with Strategic Management) · Advanced Financial Management
Case: Veda Motors Ltd (EPS Rs 40, 10 crore shares) acquires Sundaram Auto Components Ltd (net profit Rs 90 crore, 3 crore shares) by issuing 2.4 crore Veda shares to SACL holders. No synergies. Which statement about the post-merger EPS is correct?
Post-merger EPS is Rs 39.52, which is lower than Veda's existing Rs 40, so the deal is dilutive. Combined earnings of Rs 490 crore are spread over 12.4 crore shares, being 10 crore existing plus 2.4 crore newly issued.
- APost-merger EPS is Rs 39.52 and EPS of Veda is dilutedCorrect
- BPost-merger EPS is Rs 41.94 and EPS of Veda is accretive
- CPost-merger EPS is Rs 40.00 and EPS is unchanged
- DPost-merger EPS is Rs 36.00 and EPS of Veda is diluted
Explanation
Veda's earnings = 40 x 10 = Rs 400 crore. Combined earnings = Rs 490 crore. Total shares = 10 + 2.4 = 12.4 crore. EPS = 490/12.4 = Rs 39.52, below Rs 40, so there is dilution. Rs 41.94 would result from using 11.68 crore shares, a wrong share count.
Did you get it right without looking?
One question tells you little. A timed set on Advanced Financial Management shows your real accuracy, how long you take and where you lose marks.
More Advanced Financial Management questions
- Case: Kaveri Polymers Ltd is evaluating a new moulding line costing Rs 80 lakh, with an expected life of 4 years and nil salvage value. Annu…
- Case: Godavari Steels Ltd has two mutually exclusive projects, both with a 10% cost of capital. Project P: outlay Rs 10 lakh, PV of inflows …
- Case: Sanvi Pharma Ltd is demerging its API division into a new company, with shares issued proportionately to Sanvi's shareholders. Which d…
- Case: Meera Foods Ltd (equity Rs 40 crore) is considering a leveraged buyout of a division funded 80% by debt. The division generates stable…
- Case: Kaveri Foods Ltd is considering acquiring Malabar Spices Ltd through a purchase of its business in which Malabar's shareholders keep n…
- Case: Meridian Pharma Ltd, Hyderabad, has a UK subsidiary. In India, expected inflation is 6% p.a. and in the UK 2% p.a. Spot is Rs 105.00/G…